Esperion Therapeutics Inc Financial Flexibility Index
Esperion Therapeutics Inc financial flexibility index. Esperion Therapeutics Inc (ESPR) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of $-4.29 Million (operating CF $-4.29 Million minus capex $0.00) represents 0% of total liabilities ($815.38 Million). See Esperion Therapeutics Inc (ESPR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Esperion Therapeutics Inc (1999–2024)
Financial flexibility index of Esperion Therapeutics Inc from 1999 to 2024. Historical Financial Flexibility Index trend for Esperion Therapeutics Inc across 18 annual periods. Check Esperion Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Esperion Therapeutics Inc Financial Flexibility Index by Year (1999–2024)
Esperion Therapeutics Inc financial flexibility index by year from 1999 to 2024. Year-by-year free cash flow to debt coverage for Esperion Therapeutics Inc. For the full cash flow conversion analysis, see ESPR cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.03x | $-23.34 Million | $-23.65 Million | $732.54 Million | ▲ +84.5% |
| 2023 | -0.21x | $-135.49 Million | $-135.49 Million | $660.79 Million | ▲ +32.9% |
| 2022 | -0.31x | $-174.83 Million | $-174.83 Million | $571.72 Million | ▲ +32.9% |
| 2021 | -0.46x | $-263.81 Million | $-263.81 Million | $578.53 Million | ▼ -185.4% |
| 2020 | -0.16x | $-71.81 Million | $-85.18 Million | $449.39 Million | ▲ +55.2% |
| 2019 | -0.36x | $-69.39 Million | $-70.34 Million | $194.50 Million | ▲ +84.5% |
| 2018 | -2.31x | $-148.49 Million | $-148.64 Million | $64.33 Million | ▲ +41.7% |
| 2017 | -3.96x | $-131.28 Million | $-131.30 Million | $33.14 Million | ▼ -38.1% |
| 2016 | -2.87x | $-47.64 Million | $-47.73 Million | $16.61 Million | ▲ +37.0% |
| 2015 | -4.55x | $-37.83 Million | $-38.16 Million | $8.31 Million | ▼ -43.0% |
| 2014 | -3.18x | $-31.15 Million | $-32.02 Million | $9.79 Million | ▲ +26.1% |
| 2013 | -4.30x | $-18.08 Million | $-18.11 Million | $4.20 Million | ▼ -884.0% |
| 2012 | -0.44x | $-10.80 Million | $-10.81 Million | $24.70 Million | ▲ +60.1% |
| 2011 | -1.10x | $-9.04 Million | $-9.07 Million | $8.24 Million | ▲ +45.3% |
| 2002 | -2.01x | $-25.41 Million | $-26.56 Million | $12.66 Million | ▼ -14.5% |
| 2001 | -1.75x | $-20.74 Million | $-22.77 Million | $11.84 Million | ▼ -7.4% |
| 2000 | -1.63x | $-16.61 Million | $-17.95 Million | $10.19 Million | ▼ -34.4% |
| 1999 | -1.21x | $-6.29 Million | $-7.85 Million | $5.18 Million | — |